Proietto, Joseph
Malloy, Jaret
Zhuang, Dongliang
Arya, Mark
Cohen, Neale D.
de Looze, Ferdinandus J.
Gilfillan, Christopher
Griffin, Paul
Hall, Stephen
Nathow, Thomas
Oldfield, Geoffrey S.
O’Neal, David N.
Roberts, Adam
Stuckey, Bronwyn G. A.
Yue, Dennis
Taylor, Kristin
Kim, Dennis
Funding for this research was provided by:
Zafgen, Inc.
Article History
Received: 14 March 2018
Accepted: 24 May 2018
First Online: 11 July 2018
Duality of interest
: JP, MA, FJdL, CG, PG, SH, TN, GSO, DNO, AR and DY received institutional grant support from Zafgen. NDC received institutional support from Zafgen and advisory board/speaking fees from Boehringer-Ingelheim, Lilly, Novo Nordisk, Astra Zeneca, Medtronic, Servier and Abbott. BGAS received institutional grant support from Zafgen and speaking fees from Bayer and Besins. JM, DZ, KT and DK are employees of, and hold stock in, Zafgen.